Financials
| Half-year Report | Sep. 27, 2024 |
| Final Results and Notice of AGM | May. 15, 2024 |
| Half-year Report | Aug. 24, 2023 |
| Half-year Report | Aug. 31, 2022 |
| Annual Report, AGM Notice & Director Resignation | Jun. 07, 2022 |
| Half-year Report | Sep. 07, 2021 |
| Final Results | Apr. 27, 2021 |
Proxies
| Result of AGM | Jun. 20, 2024 |
| Result of AGM | Jun. 28, 2023 |
| Result of AGM | May. 27, 2021 |
| Posting of Annual Report and Notice of AGM | Apr. 30, 2021 |
| Result of AGM | Jul. 23, 2020 |
| AGM Statement | Jul. 23, 2020 |
| AGM Arrangements | Jul. 17, 2020 |
Ownership Update
| Holding(s) in Company | Jun. 06, 2025 |
| Holding(s) in Company | May. 20, 2025 |
| Holding(s) in Company | Jan. 15, 2025 |
| Holding(s) in Company | Jan. 15, 2025 |
| Holding(s) in Company | Jan. 14, 2025 |
| Holding(s) in Company | Jan. 09, 2025 |
| Holding(s) in Company | Jan. 08, 2025 |
Announcements
| Ambrose Exercise Option on VAL401 | Jun. 20, 2025 |
| ValiRx Investor Webinar | Jun. 09, 2025 |
| New Evaluation and Material Transfer Agreement | Jun. 03, 2025 |
| Inaphaea Deal Extension With Dominion | May. 12, 2025 |
| Commercial Update | Apr. 30, 2025 |
| Termination of Letter of Intent with TheoremRx | Apr. 03, 2025 |
| Directorate Changes and new Advisory Board | Mar. 27, 2025 |